Department of Laboratory Medicine and Pathology, U. of Minnesota Medical School, Minneapolis, MN, United States.
Division of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, United States.
J Microbiol Methods. 2014 Feb;97:15-9. doi: 10.1016/j.mimet.2013.12.003. Epub 2013 Dec 12.
Pertussis is an infectious respiratory disease caused by the fastidious bacterium Bordetella pertussis, which may infect unvaccinated, previously vaccinated children, and adults in whom immunity has waned. Infants are at a particular risk for severe disease and complications. Bordetella parapertussis may cause a similar illness, however the symptoms are less severe and of shorter duration. Pertussis is a highly contagious disease and early diagnosis is essential. Studies have shown that PCR is 2-4 times more likely than culture to detect Bordetella pertussis. We developed a multiplex, real-time PCR assay using analyte-specific reagent (ASR) primers and probes dispensed in a convenient lyophilized bead format that targeted the multi-copy insertion sequences IS481 and IS1001 of B. pertussis and B. parapertussis, respectively. These specific ASRs were used in conjunction with Cepheid Smartmix. Included in the ASRs is a competitive internal control to evaluate the performance of the PCR reaction. After DNA extraction, amplification and detection were done on the Smart Cycler System, which performs integrated amplification and detection automatically in a single step. Specificity of the assay was confirmed using multiple distinct bacterial strains. Sensitivity of the assay and extraction efficiency were evaluated on DNA isolated from pure bacterial cultures and on spiked respiratory specimens. We also spiked different swab types and transport media to evaluate for interfering substances. To assess accuracy, we studied different patient specimen types received from two outside laboratories that used similar or different methods to detect B. pertussis and B. parapertussis. The sensitivity and the specificity of the assay for B. pertussis were 90% and 96%, respectively, and for B. parapertussis 71% (only 7 positive specimens were available for testing) and 100%, respectively. Our assay was found to be a valid method for the simultaneous detection of B. pertussis and B. parapertussis.
百日咳是一种由苛养的百日咳博德特氏菌引起的传染性呼吸道疾病,可感染未接种疫苗、既往接种疫苗但免疫力减弱的儿童和成人。婴儿尤其容易患严重疾病和并发症。副百日咳博德特氏菌也可能引起类似的疾病,但症状较轻且持续时间较短。百日咳是一种高度传染性疾病,早期诊断至关重要。研究表明,PCR 比培养法检测百日咳博德特氏菌的可能性高 2-4 倍。我们开发了一种多重实时 PCR 检测方法,使用分析物特异性试剂(ASR)引物和探针,并以方便的冻干珠形式分配,分别针对百日咳博德特氏菌和副百日咳博德特氏菌的多拷贝插入序列 IS481 和 IS1001。这些特定的 ASR 与 Cepheid Smartmix 一起使用。ASR 中包含一个竞争内部对照,以评估 PCR 反应的性能。在 Smart Cycler 系统上进行 DNA 提取、扩增和检测,该系统在单个步骤中自动进行集成扩增和检测。使用多种不同的细菌株确认了该检测方法的特异性。在从纯细菌培养物和添加的呼吸道标本中提取的 DNA 上评估了检测方法的灵敏度和提取效率。我们还在不同的拭子类型和转运培养基中添加了添加物,以评估干扰物质。为了评估准确性,我们研究了从两个外部实验室收到的不同患者标本类型,这些实验室使用类似或不同的方法来检测百日咳博德特氏菌和副百日咳博德特氏菌。该检测方法对百日咳博德特氏菌的灵敏度和特异性分别为 90%和 96%,对副百日咳博德特氏菌的灵敏度和特异性分别为 71%(仅 7 个阳性标本可供检测)和 100%。我们的检测方法被证明是一种同时检测百日咳博德特氏菌和副百日咳博德特氏菌的有效方法。